OrthoPediatrics (KIDS) Stock Price, News & Analysis

Company Overview

OrthoPediatrics Corp. is a medical device company focused exclusively on developing and commercializing orthopedic products for children. Headquartered in Warsaw, Indiana, the company designs implants and instruments intended to address the distinct anatomical and clinical needs of pediatric patients, including those whose bones are still growing.

Its product portfolio includes systems for pediatric trauma and deformity correction, scoliosis treatment, limb reconstruction, and pediatric sports medicine. Key product lines include the PediLoc and PediPlates systems, which are designed for fracture fixation and corrective procedures, as well as specialized implants and instrumentation used by orthopedic surgeons in treating congenital conditions, growth-related deformities, and other musculoskeletal disorders.

Founded in 2006, OrthoPediatrics markets its products through a direct sales organization and distribution partners to children's hospitals, medical centers, and orthopedic practices. The company serves customers in the United States and international markets, supporting pediatric orthopedic surgeons and healthcare providers in multiple regions. David Bailey has served as the company's chief executive officer.

Key Stats

• Today's Range: $21.91 to $22.72
• 50-Day Range: $21.56 to $26.50
• 52-Week Range: $14.42 to $26.74
• Volume: 149,674 shs
• Average Volume: 176,184 shs
• Market Capitalization: $573.11 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $26.50
• Consensus Rating: Moderate Buy

OrthoPediatrics Stock Analysis - MarketRank™

OrthoPediatrics scored higher than 56% of companies evaluated by MarketBeat, and ranked 605th out of 870 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

OrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

OrthoPediatrics has a consensus price target of $26.50, representing about 20.7% upside from its current price of $21.95.

Amount of Analyst Coverage

OrthoPediatrics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for OrthoPediatrics are expected to grow in the coming year, from ($1.14) to ($0.83) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of OrthoPediatrics is -13.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of OrthoPediatrics is -13.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

OrthoPediatrics has a P/B Ratio of 1.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.28% of the float of OrthoPediatrics has been sold short.

Short Interest Ratio / Days to Cover

OrthoPediatrics has a short interest ratio ("days to cover") of 5.54.

Change versus previous month

Short interest in OrthoPediatrics has recently increased by 5.88%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

OrthoPediatrics does not currently pay a dividend.

Dividend Growth

OrthoPediatrics does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.62

News Sentiment

OrthoPediatrics has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for OrthoPediatrics this week, compared to 2 articles on an average week.

Search Interest

4 people have searched for KIDS on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $46,747,931.00 in company stock.

Percentage Held by Insiders

32.50% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 10/16/2026
• Next Earnings (Estimated): 10/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:KIDS
• CIK: 1425450
• Web: www.orthopediatrics.com
• Phone: (574) 268-6379
• Fax: 574-269-3692
• Employees: 602
• Year Founded: 2006

Price Target and Rating

• Average Price Target for OrthoPediatrics: $26.50
• High Price Target: $35.00
• Low Price Target: $22.00
• Potential Upside/Downside: +20.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.57
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.68)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$39.65 million
• Net Margins: -15.72%
• Pretax Margin: -15.61%
• Return on Equity: -8.10%
• Return on Assets: -5.54%

Debt

• Debt-to-Equity Ratio: 0.28
• Current Ratio: 4.78
• Quick Ratio: 2.17

Sales & Book Value

• Annual Sales: $236.35 million
• Price / Sales: 2.42
• Cash Flow: $0.16 per share
• Price / Cash Flow: 133.81
• Book Value: $13.82 per share
• Price / Book: 1.59

Miscellaneous

• Outstanding Shares: 26,110,000
• Free Float: 17,624,000
• Market Cap: $573.11 million
• Optionable: Optionable
• Beta: 0.99